AdrenoMend
En vente sur le marché américain (selon le DSLD)
Douglas Laboratories, food supplement from the US market
AdrenoMend (Douglas Laboratories), a food supplement au code-barres 310539034828, is described by its US market label, recorded on 23 August 2020. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label, entered on 23 August 2020. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Douglas Laboratories
- Barcode
- 310539034828
- Form
- Capsule
- One serving
- 4 vegetarian capsules
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Hydroxypropyl Methylcellulose, Microcrystalline Cellulose, Vegetable Stearate, Silica
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| AdrenoMend | Blend | not stated |
| A Phytocrine Proprietary Blend | Blend | 2,040 mg |
| Schisandra chinensis (Schisandra chinensis) | Plant | not stated |
| Bacopa monnieri (Bacopa monnieri) | Plant | not stated |
| Rhodiola rosea | Plant | not stated |
| Eleutherococcus senticosus (Eleutherococcus senticosus) | Plant | not stated |
| Magnolia officinalis | Plant | not stated |
| Rehmannia glutinosa (Rehmannia glutinosa) | Plant | not stated |
| Bupleurum falcatum | Plant | not stated |
| Panax ginseng (Panax ginseng) | Plant | not stated |
| Coleus forskohlii (Plectranthus barbatus) | Plant | not stated |
| Sensoril Ashwagandha extract (Withania somnifera) | Plant | 250 mg |
Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: AdrenoMend
Entered into DSLD on 23 July 2020. Retirée du marché américain le 18 May 2020 (selon le DSLD).Same active composition.
Official label: AdrenoMend
Entered into DSLD on 24 March 2016. Retirée du marché américain le 18 May 2020 (selon le DSLD).- Different unit, without conversion : AdrenoMend: 1,910 mg ; 955 mg in this version; quantity not stated on the displayed label
- Different unit, without conversion : A Phytocrine Proprietary Blend: quantity not stated ; 200 mg in this version; 1,020 mg ; 2,040 mg on the displayed label
- Different unit, without conversion : Bacopa monnieri: quantity not stated in this version; quantity not stated ; >= 200 mg on the displayed label
- Different unit, without conversion : Bupleurum falcatum: quantity not stated in this version; quantity not stated ; >= 200 mg on the displayed label
- Different unit, without conversion : Coleus forskohlii: quantity not stated in this version; quantity not stated ; >= 200 mg on the displayed label
- Different unit, without conversion : Eleutherococcus senticosus: quantity not stated in this version; quantity not stated ; >= 200 mg on the displayed label
- Different unit, without conversion : Magnolia officinalis: quantity not stated in this version; quantity not stated ; >= 200 mg on the displayed label
- Different unit, without conversion : Panax ginseng: quantity not stated in this version; quantity not stated ; >= 200 mg on the displayed label
- Different unit, without conversion : Rehmannia glutinosa: quantity not stated in this version; quantity not stated ; >= 200 mg on the displayed label
- Different unit, without conversion : Rhodiola rosea: quantity not stated in this version; quantity not stated ; >= 200 mg on the displayed label
- Different unit, without conversion : Schisandra chinensis: quantity not stated in this version; quantity not stated ; >= 200 mg on the displayed label
Official label: Adreno-Mend
Entered into DSLD on 25 April 2014. Retirée du marché américain le 15 December 2015 (selon le DSLD).- Active ingredient added : Proprietary Blend (1,910 mg ; 955 mg)
- Active ingredient added : Sensoril (125 mg ; 250 mg)
- Active ingredient removed : AdrenoMend (quantity not stated)
- Active ingredient removed : Sensoril Ashwagandha extract (125 mg ; 250 mg)
- Different unit, without conversion : Bacopa monnieri: quantity not stated in this version; quantity not stated ; >= 200 mg on the displayed label
- Different unit, without conversion : Bupleurum falcatum: quantity not stated in this version; quantity not stated ; >= 200 mg on the displayed label
- Different unit, without conversion : Coleus forskohlii: quantity not stated in this version; quantity not stated ; >= 200 mg on the displayed label
- Different unit, without conversion : Eleutherococcus senticosus: quantity not stated in this version; quantity not stated ; >= 200 mg on the displayed label
- Different unit, without conversion : Magnolia officinalis: quantity not stated in this version; quantity not stated ; >= 200 mg on the displayed label
- Different unit, without conversion : Panax ginseng: quantity not stated in this version; quantity not stated ; >= 200 mg on the displayed label
- Different unit, without conversion : Rehmannia glutinosa: quantity not stated in this version; quantity not stated ; >= 200 mg on the displayed label
- Different unit, without conversion : Rhodiola rosea: quantity not stated in this version; quantity not stated ; >= 200 mg on the displayed label
- Different unit, without conversion : Schisandra chinensis: quantity not stated in this version; quantity not stated ; >= 200 mg on the displayed label
- Quantity stated differently, without estimation : A Phytocrine Proprietary Blend: 200 mg in this version; 1,020 mg ; 2,040 mg on the displayed label
Official label: Adreno-Mend
Entered into DSLD on 21 December 2012. Retirée du marché américain le 20 January 2012 (selon le DSLD).- Active ingredient added : Proprietary Blend (1,910 mg ; 955 mg)
- Active ingredient added : Sensoril (125 mg ; 250 mg)
- Active ingredient removed : AdrenoMend (quantity not stated)
- Active ingredient removed : A Phytocrine Proprietary Blend (1,020 mg ; 2,040 mg)
- Active ingredient removed : Bacopa monnieri (quantity not stated ; >= 200 mg)
- Active ingredient removed : Bupleurum falcatum (quantity not stated ; >= 200 mg)
- Active ingredient removed : Coleus forskohlii (quantity not stated ; >= 200 mg)
- Active ingredient removed : Eleutherococcus senticosus (quantity not stated ; >= 200 mg)
- Active ingredient removed : Magnolia officinalis (quantity not stated ; >= 200 mg)
- Active ingredient removed : Panax ginseng (quantity not stated ; >= 200 mg)
- Active ingredient removed : Rehmannia glutinosa (quantity not stated ; >= 200 mg)
- Active ingredient removed : Rhodiola rosea (quantity not stated ; >= 200 mg)
- Active ingredient removed : Schisandra chinensis (quantity not stated ; >= 200 mg)
- Active ingredient removed : Sensoril Ashwagandha extract (125 mg ; 250 mg)
Official label: Adreno-Mend
Entered into DSLD on 21 December 2012. Retirée du marché américain le 31 July 2013 (selon le DSLD).- Active ingredient added : Proprietary Blend (1,910 mg ; 955 mg)
- Active ingredient added : Sensoril (125 mg ; 250 mg)
- Active ingredient removed : AdrenoMend (quantity not stated)
- Active ingredient removed : A Phytocrine Proprietary Blend (1,020 mg ; 2,040 mg)
- Active ingredient removed : Bacopa monnieri (quantity not stated ; >= 200 mg)
- Active ingredient removed : Bupleurum falcatum (quantity not stated ; >= 200 mg)
- Active ingredient removed : Coleus forskohlii (quantity not stated ; >= 200 mg)
- Active ingredient removed : Eleutherococcus senticosus (quantity not stated ; >= 200 mg)
- Active ingredient removed : Magnolia officinalis (quantity not stated ; >= 200 mg)
- Active ingredient removed : Panax ginseng (quantity not stated ; >= 200 mg)
- Active ingredient removed : Rehmannia glutinosa (quantity not stated ; >= 200 mg)
- Active ingredient removed : Rhodiola rosea (quantity not stated ; >= 200 mg)
- Active ingredient removed : Schisandra chinensis (quantity not stated ; >= 200 mg)
- Active ingredient removed : Sensoril Ashwagandha extract (125 mg ; 250 mg)
Official label: Adreno-Mend
Entered into DSLD on 23 December 2011. Retirée du marché américain le 20 January 2012 (selon le DSLD).- Active ingredient added : Proprietary Blend (1,910 mg ; 955 mg)
- Active ingredient added : Sensoril (125 mg ; 250 mg)
- Active ingredient removed : A Phytocrine Proprietary Blend (1,020 mg ; 2,040 mg)
- Active ingredient removed : Rehmannia glutinosa (quantity not stated ; >= 200 mg)
- Active ingredient removed : Sensoril Ashwagandha extract (125 mg ; 250 mg)
- Same quantity, different name: Rhemannia glutinosa in this version; AdrenoMend on the displayed label (quantity not stated)
- Different unit, without conversion : Bacopa monnieri: quantity not stated in this version; quantity not stated ; >= 200 mg on the displayed label
- Different unit, without conversion : Bupleurum falcatum: quantity not stated in this version; quantity not stated ; >= 200 mg on the displayed label
- Different unit, without conversion : Coleus forskohlii: quantity not stated in this version; quantity not stated ; >= 200 mg on the displayed label
- Different unit, without conversion : Eleutherococcus senticosus: quantity not stated in this version; quantity not stated ; >= 200 mg on the displayed label
- Different unit, without conversion : Magnolia officinalis: quantity not stated in this version; quantity not stated ; >= 200 mg on the displayed label
- Different unit, without conversion : Panax ginseng: quantity not stated in this version; quantity not stated ; >= 200 mg on the displayed label
- Different unit, without conversion : Rhodiola rosea: quantity not stated in this version; quantity not stated ; >= 200 mg on the displayed label
- Different unit, without conversion : Schisandra chinensis: quantity not stated in this version; quantity not stated ; >= 200 mg on the displayed label
Source
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
List recorded in 2020. Photograph the packaging to check whether it has changed. Photograph the packaging
Brand : Douglas Laboratories